The regulatory journey from PFAS’s discovery as a contaminant to current EPA limits spans decades and reflects the challenges of regulating persistent contaminants with complex health effects under an evolving scientific and legal landscape. Understanding this history contextualizes current regulations and filtration needs.
Early Recognition (1990s–2000s)
PFOS and PFOA were identified in environmental and human samples in the 1990s, with C8 Science Panel studies in West Virginia communities near DuPont’s Washington Works plant providing critical epidemiological data. EPA began investigating PFAS in the early 2000s, issuing a draft risk assessment for PFOA in 2005 and negotiating the 2006 PFOA Stewardship Program with major manufacturers to phase out PFOA and related compounds by 2015.
Health Advisory Era (2009–2022)
EPA issued provisional health advisories for PFOA and PFOS in 2009, establishing guidance values without enforceable limits. The 2016 lifetime health advisory of 70 ppt for combined PFOA and PFOS marked the first widely implemented federal guidance, driving many utilities to investigate and treat their supplies. Non-enforceable advisories created inconsistent state responses — some states set lower state-level limits while others waited for federal MCLs.
2024 Final Rule and Current Context
EPA’s April 2024 final rule established legally enforceable MCLs for six PFAS, with PFOA and PFOS at 4 ppt — the lowest technically achievable with current methods. Public water systems have until April 2029 for compliance, driving the current wave of utility treatment investment. For household filtration, the 4 ppt standard provides the benchmark against which filter performance should be evaluated when selecting treatment for drinking water protection.